Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain

(1) Background: Intravesical mitomycin-C (MMC) combined with hyperthermia is increasingly used in non-muscle invasive bladder cancer (NMIBC), especially in the context of a relative BCG shortage. We aim to determine real-world data on the long-term treatment outcomes of adjunct hyperthermic intraves...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ana Plata, Félix Guerrero-Ramos, Carlos Garcia, Alejandro González-Díaz, Ignacio Gonzalez-Valcárcel, José Manuel de la Morena, Francisco Javier Díaz-Goizueta, Julio Fernández del Álamo, Victoria Gonzalo, Javier Montero, Alejandro Sousa-Escandón, Juan León, Jose Luis Pontones, Francisco Delgado, Miguel Adriazola, Ángela Pascual, Jesús Calleja, Ana Ruano, Luis Martínez-Piñeiro, Javier C. Angulo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
bladder neoplasia
hyperthermic intravesical chemotherapy
mitomycin-C
bladder recirculation system
Medicine
R
Acceso en línea:https://doaj.org/article/9b65c64de03b41c6bd661e55f2401221
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares